secwatch.observer — SEC 8-K summary
======================================

Issuer:     Outset Medical, Inc. (OM)
CIK:        0001484612
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0000950170-24-002731
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Outset Medical reports Q4 rev $30.5M, FY2023 $130M (+13%), guides 2024 rev $145-153M
--------------------------------------------------------------------------------

- Q4 revenue $30.5M; FY2023 revenue $130M, up 13% YoY.
- Installed base up 34% YoY to ~5,350 Tablo systems; consumable revenue grew nearly 50% YoY.
- Recurring revenue exceeded 50% of total revenue in 2023.
- Borrowed $66.5M in Jan 2024; cash position ~$270M.
- 2024 guidance: revenue $145-153M (12-18% growth); non-GAAP gross margin low-30% for year, mid-30% in Q4.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1484612/000095017024002731/0000950170-24-002731-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1484612/000095017024002731/om-20240108.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-002731

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer